Amazing big spikes
Release time:
2020-08-14
Great Big Peak
In the group's QQ group and WeChat group, I often see colleagues with titles such as "Daye Peak" and "Tianjin Peak" in front of their names communicate with each other, but at that time I didn't think carefully about how these brothers and sisters from all over the world and such a large team come together. In this economy, it is not very prosperous, in the era of fierce market competition, what kind of great enterprise should the peak be able to fight north and south like a broken bamboo and keep moving forward? It is a great honor that I am also a member of the big family of Jianfeng. What's more, on the 8th birthday of Jianfeng 60#, I can fly over Qian Shan Wanshui from Pu'er, Yunnan Province, to the headquarters and celebrate with colleagues from other places! Before
arrived at the group headquarters, the peak building was seen standing solemnly by the Jinhua river from a distance. Stepping into the gate of the peak building, I feel like I have returned to my home that I have been away for a long time. I am strange but familiar, and I am inexplicably excited. In the exhibition hall of the group company, editor-in-chief fu of the peak newspaper told us about the growth of peak 60 .
The first thing that caught our attention was, of course, the development of the spike. 1958 , when we were not yet born, our ancestors came to the wise temple east of qianzhuangtou village in anshi township (now luodian town), kilometers north of Jinhua city. with a pair of hands and passion, they built Jinhua's first cement factory on the desolate hillside of 16.94 mu and began the process of hard work. The pictures of "cattle pulling into a ball" and "barrel into a ball" on the display board not only show the backward technology and the difficult conditions at that time, but also reflect the drive in the bones of the ancestors and their determination to win. Seeing these pictures, my heart is full of admiration, sincerely admire the ancestors of the peak, and planted this evergreen tree for us latecomers!
Next is a panorama of the Jinhua cement plant. Editor-in-chief fu told us that during the period from 1984 to , under the new situation of national reform and opening up, Jinhua cement factory held high the banner of reform, improved various basic management systems, adjusted and strengthened the leading group, broke the boundary of ownership through horizontal alliance with township enterprises, realized the first leap in enterprise development, expanded the scale of the enterprise rapidly, and formed a cement group, the successful transformation of the shareholding system has accumulated energy for the take-off of the enterprise. Next to it is also displayed the first stock issued after the implementation of the shareholding system. Although we didn't feel the joy and benefit that the stock brought to the peak people at that time, but looking at these, our hearts are also extremely proud and proud! The pictures in the
exhibition hall let us feel the twists and turns of the development of the peak, and also let us know more about the brother enterprises in the peak family. For example, Jianfeng Pharmaceutical, which we have never come into contact with before, is a comprehensive pharmaceutical enterprise integrating science, industry and trade, with the development, production and operation of various chemical source drugs and preparations, proprietary Chinese medicines, and biological preparations as its main business. it is a national high-tech enterprise, a national-level industrialization project demonstration enterprise, and one of the top 100 pharmaceutical enterprises in China. In line with the enterprise spirit of "establishing peak ambition and making high-quality medicine", Jianfeng Pharmaceutical Company pursues the business philosophy of "science and technology to create health" and "innovation to enhance medicine". Focus on developing new products with high added value, high-tech content and independent intellectual property rights, and implement the "going out" strategy, participate in international competition, open up new markets, and strive to cultivate Jianfeng Pharmaceutical into a strong scale and strength, and there is a higher level of profitability of the new enterprise ...... Hearing this, our hearts surged with ambition.
60 years of development, the peak from a small state-owned factory, grew into a comprehensive modern joint-stock enterprise, and formed its own unique corporate culture. Through thinking innovation, technological innovation, management innovation, and mechanism innovation, the peak keeps the company vigorous and vigorous in the continuous change; through the formulation of practical development strategies, continuous strengthening of execution and risk avoidance capabilities, our company has achieved A healthy and stable development; through the establishment of a modern enterprise system, effective democratic management, system construction and scientific management of enterprises, our spikes are full of vitality. Moreover, while making great contributions to the local economy, Jianfeng also strives to repay the society, actively undertakes social responsibilities, loves charity and public welfare undertakings, helps the poor and the needy, donates money to schools, and promotes social harmony and prosperity... Seeing these, I think of our Yunnan Jianfeng. Although it has been put into production for only a short period of 5 years, we have worked hard to spend every day and night in every ordinary post, every love we give to the people in the disaster areas, and every bit of support we give to the poor villages, do not fully prove all this? In the exhibition hall
, there is a sentence that is particularly impressive, "We are committed to being a respected company and an admired company". Now, the photo of this sentence is stored in my mobile phone. Every time I see this sentence, I will urge me to work hard. I believe that on the road to the "Centennial Peak" in the future, we, the peak people from all over the world, will unite as one and build together! (Luo Meiyan)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31